Becton Dickinson Return on Investment 2012-2026 | BDX
Current and historical return on investment (ROI) values for Becton Dickinson (BDX) over the last 10 years.
| Becton Dickinson ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-03-31 | $2.22B | $41.76B | 5.32% |
| 2025-12-31 | $2.68B | $42.78B | 6.25% |
| 2025-09-30 | $2.58B | $42.89B | 6.01% |
| 2025-06-30 | $2.51B | $43.10B | 5.82% |
| 2025-03-31 | $2.23B | $43.35B | 5.14% |
| 2024-12-31 | $2.41B | $43.03B | 5.61% |
| 2024-09-30 | $2.40B | $42.22B | 5.68% |
| 2024-06-30 | $2.13B | $41.40B | 5.13% |
| 2024-03-31 | $2.07B | $40.62B | 5.10% |
| 2023-12-31 | $1.96B | $40.63B | 4.83% |
| 2023-09-30 | $2.11B | $40.71B | 5.19% |
| 2023-06-30 | $2.25B | $40.37B | 5.57% |
| 2023-03-31 | $2.24B | $40.20B | 5.57% |
| 2022-12-31 | $2.18B | $40.30B | 5.40% |
| 2022-09-30 | $2.28B | $40.49B | 5.64% |
| 2022-06-30 | $1.88B | $40.90B | 4.59% |
| 2022-03-31 | $1.83B | $40.81B | 4.49% |
| 2021-12-31 | $1.70B | $40.92B | 4.15% |
| 2021-09-30 | $2.25B | $40.98B | 5.49% |
| 2021-06-30 | $1.85B | $41.03B | 4.51% |
| 2021-03-31 | $1.72B | $41.35B | 4.15% |
| 2020-12-31 | $1.65B | $40.15B | 4.12% |
| 2020-09-30 | $0.91B | $39.50B | 2.31% |
| 2020-06-30 | $1.34B | $39.05B | 3.43% |
| 2020-03-31 | $1.61B | $38.65B | 4.16% |
| 2019-12-31 | $1.38B | $38.92B | 3.53% |
| 2019-09-30 | $1.76B | $39.19B | 4.49% |
| 2019-06-30 | $2.22B | $39.37B | 5.65% |
| 2019-03-31 | $2.11B | $39.92B | 5.28% |
| 2018-12-31 | $2.16B | $41.14B | 5.25% |
| 2018-09-30 | $1.51B | $42.17B | 3.58% |
| 2018-06-30 | $1.42B | $40.10B | 3.55% |
| 2018-03-31 | $0.69B | $37.46B | 1.84% |
| 2017-12-31 | $0.95B | $30.79B | 3.08% |
| 2017-09-30 | $1.52B | $24.11B | 6.31% |
| 2017-06-30 | $1.13B | $20.75B | 5.44% |
| 2017-03-31 | $1.87B | $17.61B | 10.61% |
| 2016-12-31 | $1.89B | $17.98B | 10.50% |
| 2016-09-30 | $1.43B | $18.35B | 7.79% |
| 2016-06-30 | $1.63B | $18.44B | 8.83% |
| 2016-03-31 | $1.25B | $18.44B | 6.77% |
| 2015-12-31 | $1.08B | $18.63B | 5.78% |
| 2015-09-30 | $1.07B | $17.86B | 6.01% |
| 2015-06-30 | $1.18B | $15.43B | 7.65% |
| 2015-03-31 | $1.49B | $13.07B | 11.40% |
| 2014-12-31 | $1.58B | $10.51B | 15.00% |
| 2014-09-30 | $1.61B | $8.97B | 17.90% |
| 2014-06-30 | $1.28B | $8.97B | 14.29% |
| 2014-03-31 | $1.24B | $8.80B | 14.10% |
| 2013-12-31 | $1.24B | $8.62B | 14.40% |
| 2013-09-30 | $1.26B | $8.47B | 14.82% |
| 2013-06-30 | $1.57B | $8.24B | 19.02% |
| 2013-03-31 | $1.61B | $8.12B | 19.84% |
| 2012-12-31 | $1.61B | $8.14B | 19.81% |
| 2012-09-30 | $1.56B | $8.26B | 18.87% |
| 2012-06-30 | $1.53B | $8.11B | 18.90% |
| 2012-03-31 | $1.53B | $8.06B | 19.00% |
| 2011-12-31 | $1.59B | $7.85B | 20.24% |
| 2011-09-30 | $1.66B | $7.51B | 22.16% |
| 2011-06-30 | $1.62B | $7.42B | 21.79% |
| 2011-03-31 | $1.59B | $7.13B | 22.33% |
| 2010-12-31 | $1.57B | $6.90B | 22.71% |
| 2010-09-30 | $1.58B | $6.74B | 23.48% |
| 2010-06-30 | $1.65B | $6.67B | 24.69% |
| 2010-03-31 | $1.66B | $6.68B | 24.78% |
| 2009-12-31 | $1.60B | $6.41B | 25.01% |
| 2009-09-30 | $1.59B | $6.10B | 26.07% |
| 2009-06-30 | $1.55B | $5.91B | 26.16% |
| 2009-03-31 | $1.52B | $5.75B | 26.50% |
| 2008-12-31 | $1.54B | $5.81B | 26.56% |
| 2008-09-30 | $1.49B | $5.81B | 25.65% |
| 2008-06-30 | $1.48B | $5.66B | 26.10% |
| 2008-03-31 | $1.40B | $5.45B | 25.65% |
| 2007-12-31 | $1.33B | $5.27B | 25.33% |
| 2007-09-30 | $1.19B | $5.12B | 23.15% |
| 2007-06-30 | $1.15B | $4.99B | 23.12% |
| 2007-03-31 | $1.11B | $4.82B | 23.08% |
| 2006-12-31 | $1.05B | $4.66B | 22.41% |
| 2006-09-30 | $1.14B | $4.53B | 25.19% |
| 2006-06-30 | $1.15B | $4.42B | 25.90% |
| 2006-03-31 | $1.12B | $4.38B | 25.55% |
| 2005-12-31 | $1.12B | $4.39B | 25.63% |
| 2005-09-30 | $1.06B | $4.40B | 24.21% |
| 2005-06-30 | $1.02B | $4.37B | 23.37% |
| 2005-03-31 | $0.90B | $4.34B | 20.65% |
| 2004-12-31 | $0.87B | $4.30B | 20.21% |
| 2004-09-30 | $0.79B | $4.26B | 18.49% |
| 2004-06-30 | $0.77B | $4.22B | 18.17% |
| 2004-03-31 | $0.80B | $4.19B | 19.20% |
| 2003-12-31 | $0.77B | $3.98B | 19.37% |
| 2003-09-30 | $0.76B | $3.77B | 20.18% |
| 2003-06-30 | $0.72B | $3.57B | 20.16% |
| 2003-03-31 | $0.71B | $3.37B | 21.14% |
| 2002-12-31 | $0.69B | $3.28B | 21.05% |
| 2002-09-30 | $0.68B | $3.22B | 20.97% |
| 2002-06-30 | $0.67B | $3.18B | 20.94% |
| 2002-03-31 | $0.67B | $3.10B | 21.48% |
| 2001-12-31 | $0.66B | $3.04B | 21.68% |
| 2001-09-30 | $0.64B | $3.04B | 20.99% |
| 2001-06-30 | $0.61B | $2.95B | 20.57% |
| 2001-03-31 | $0.59B | $2.88B | 20.46% |
| 2000-12-31 | $0.57B | $2.83B | 20.22% |
| 2000-09-30 | $0.57B | $2.73B | 20.93% |
| 2000-06-30 | $0.56B | $2.73B | 20.48% |
| 2000-03-31 | $0.54B | $2.65B | 20.26% |
| 1999-12-31 | $0.53B | $2.59B | 20.51% |
| 1999-09-30 | $0.52B | $2.51B | 20.75% |
| 1999-06-30 | $0.53B | $2.42B | 22.03% |
| 1999-03-31 | $0.50B | $2.38B | 21.18% |
| 1998-12-31 | $0.50B | $2.28B | 22.14% |
| 1998-09-30 | $0.50B | $2.26B | 21.95% |
| 1998-06-30 | $0.48B | $2.18B | 22.23% |
| 1998-03-31 | $0.49B | $2.07B | 23.68% |
| 1997-12-31 | $0.47B | $2.00B | 23.32% |
| 1997-09-30 | $0.45B | $1.86B | 24.15% |
| 1997-06-30 | $0.44B | $1.80B | 24.40% |
| 1997-03-31 | $0.45B | $1.77B | 25.72% |
| 1996-12-31 | $0.45B | $1.77B | 25.12% |
| 1996-09-30 | $0.43B | $1.80B | 24.00% |
| 1996-06-30 | $0.43B | $1.84B | 23.20% |
| 1996-03-31 | $0.42B | $1.91B | 21.76% |
| 1995-12-31 | $0.41B | $1.96B | 20.82% |
| 1995-09-30 | $0.40B | $1.99B | 19.94% |
| 1995-06-30 | $0.40B | $2.04B | 19.37% |
| 1995-03-31 | $0.38B | $2.09B | 18.22% |
| 1994-12-31 | $0.37B | $2.11B | 17.42% |
| 1994-09-30 | $0.36B | $2.13B | 16.72% |
| 1994-06-30 | $0.32B | $2.13B | 15.00% |
| 1994-03-31 | $0.31B | $2.16B | 14.23% |
| 1993-12-31 | $0.29B | $2.20B | 13.31% |
| 1993-09-30 | $0.30B | $2.23B | 13.29% |
| 1993-06-30 | $0.32B | $2.27B | 14.23% |
| 1993-03-31 | $0.33B | $2.24B | 14.72% |
| 1992-12-31 | $0.34B | $2.20B | 15.40% |
| 1992-09-30 | $0.33B | $2.16B | 15.24% |
| 1992-06-30 | $0.31B | $2.12B | 14.80% |
| 1992-03-31 | $0.30B | $2.08B | 14.65% |
| 1991-12-31 | $0.30B | $2.06B | 14.77% |
| 1991-09-30 | $0.31B | $2.01B | 15.60% |
| 1991-06-30 | $0.32B | $1.96B | 16.49% |
| 1991-03-31 | $0.32B | $1.89B | 16.86% |
| 1990-12-31 | $0.31B | $1.81B | 17.35% |
| 1990-09-30 | $0.31B | $1.74B | 17.54% |
| 1990-06-30 | $0.29B | $1.67B | 17.18% |
| 1990-03-31 | $0.27B | $1.60B | 17.06% |
| 1989-12-31 | $0.26B | $1.54B | 16.83% |
| 1989-09-30 | $0.26B | $1.51B | 16.93% |
| 1989-06-30 | $0.24B | $1.47B | 15.94% |
| 1989-03-31 | $0.24B | $1.46B | 16.69% |
| 1988-12-31 | $0.24B | $1.45B | 16.68% |
| 1988-09-30 | $0.24B | $1.41B | 16.94% |
| 1988-06-30 | $0.25B | $1.38B | 18.18% |
| 1988-03-31 | $0.24B | $1.35B | 17.76% |
| 1987-12-31 | $0.23B | $1.31B | 17.60% |
| 1987-09-30 | $0.22B | $1.27B | 17.37% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |